Dublin, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The "E.coli Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology; End User; and Geography" report has been added to ResearchAndMarkets.com's offering.
The global E. coli testing market is expected to reach US $2,527.73 million by 2027 from US $1,506.95 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The market growth is attributed to the key factors such as increasing E. coli testing, growing product innovations, and rising research activities. However, testing challenges is the major factor hindering the market growth.
The advancements in the healthcare sector have encouraged various researchers to develop different techniques to identify bacterial presence. The integration of biotechnology and medical device manufacturing has resulted in innovative techniques to identify the E. coli. Multiple companies have innovated rapid E. coli test kits that can identify the bacterial presence in a single day. In addition, the rising numbers of start-ups are involved in the development of such devices for the detection of E. coli. For instance, Hygiena, LLC, offers MicroSnap E. coli Test Kit that detects and enumerates the E. coli bacteria. The device is in the form of a pen that enumerates E. coli in 6 hours, without any specific sample preparation requirements. The company offers several variants of the device that can be used for different volumes of samples. The device can be used in applications such as raw material testing, manufacturing or processing plant monitoring, and finished product testing. Thus, such innovations are likely to encourage other companies to enhance their product development capabilities and launch innovative devices in the market. Moreover, various local and international companies are investing in product innovation and product launches.
The global E. coli testing market is segmented by technology and end user. Based on technology, the market is segmented into monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging. The monoclonal antibodies segment held the largest share of the market in 2019; however, the immunoassays segment is anticipated to register the highest CAGR during the forecast period. Based on end user, the E. coli testing market has been segmented into commercial or private labs, physician offices, hospitals, public health labs, and academic research institutes. The public health labs segment held the largest share of the market in 2019, whereas the academic research institutes segment is estimated to register the highest CAGR during the forecast period.
The US Department of Agriculture's Agricultural Research Service, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Indian Institute of Technology (IIT) Kanpur, Environmental Protection Agency, Department of Water Affairs in the Ministry of Water and Environmental Affairs, and European Centre for Disease Prevention and Control are among the essential secondary sources refereed to while preparing this report.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the E. coli testing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global E. coli testing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global E. coli Testing Market - By Technology
1.3.2 Global E. coli Testing Market - By End User
1.3.3 Global E. coli Testing Market - By Geography
2. E. coli Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. E. coli Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. E. coli Testing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing E. coli Testing
5.1.2 Growing Product Innovations
5.1.3 Rising Research Activities
5.2 Market Restraints
5.2.1 Testing Challenges
5.3 Market Opportunities
5.3.1 Growth Opportunities in Developing Regions
5.4 Future Trends
5.4.1 Developments in Biotechnology
5.5 Impact Analysis
6. E. coli Testing Market - Global Analysis
6.1 Global E. coli Testing Market Revenue Forecast And Analysis
6.2 Global E. coli Testing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. E. coli Testing Market- By Technology
7.1 Overview
7.2 E. coli Testing Market Share, by Technology, 2019 and 2027 (%)
7.3 Monoclonal Antibodies
7.3.1 Overview
7.3.2 Monoclonal Antibodies: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.4 Differential Light Scattering
7.4.1 Overview
7.4.2 Differential Light Scattering: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.6 Immunoassays
7.6.1 Overview
7.6.2 Immunoassays: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.7 Chromatography
7.7.1 Overview
7.7.2 Chromatography: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.8 Flow Cytometry
7.8.1 Overview
7.8.2 Flow Cytometry: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.9 Gel Microdroplets
7.9.1 Overview
7.9.2 Gel Microdroplets: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
7.10 Diagnostic Imaging
7.10.1 Overview
7.10.2 Diagnostic Imaging: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
8. E. coli Testing Market- By End User
8.1 Overview
8.2 E. coli Testing Market Share, by End User, 2019 and 2027 (%)
8.3 Commercial or Private Labs
8.3.1 Overview
8.3.2 Commercial or Private Labs: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
8.4 Physician Offices
8.4.1 Overview
8.4.2 Physician Offices: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
8.5 Hospitals
8.5.1 Overview
8.5.2 Hospitals: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
8.6 Public Health Labs
8.6.1 Overview
8.6.2 Public Health Labs: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
8.7 Academic Research Institutes
8.7.1 Overview
8.7.2 Academic Research Institutes: E. coli Testing Market Market- Revenue and Forecast to 2027 (USD Million)
9. E. coli Testing Market - Geographic Analysis
9.1 North America: E. coli Testing Market
9.2 Europe: E. coli Testing Market
9.3 Asia Pacific: E. coli Testing Market
9.4 Middle East & Africa: E. coli Testing Market
9.5 South and Central America: E. coli Testing Market
10. Impact of COVID-19 Pandemic On Global E. coli Testing Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. E. coli Testing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 BIO-RAD LABORATORIES INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pro Lab Diagnostics Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 IDEXX LABORATORIES, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 MERIDIAN BIOSCIENCE, INC.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 THERMO FISHER SCIENTIFIC INC.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NEOGEN Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hologic, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/r/edkd22
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.